Clinical trials
Completed Phase 4 Migraine Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
101 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 5 |
| 2005 | 5 |
| 2006 | 4 |
| 2007 | 3 |
| 2008 | 5 |
| 2009 | 8 |
| 2010 | 7 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 8 |
| 2015 | 5 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 11 |
| 2020 | 7 |
| 2021 | 3 |
| 2022 | 5 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 101 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Montefiore Medical Center | 9 |
| Amgen | 5 |
| Cady, Roger, M.D. | 5 |
| Pfizer | 4 |
| Allergan | 3 |
| Clinvest | 3 |
| Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | 3 |
| Novartis Pharmaceuticals | 3 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 3 |
| AstraZeneca | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Migraine Disorders | 101 |
| Headache | 25 |
| Emergencies | 5 |
| Migraine with Aura | 4 |
| Migraine without Aura | 4 |
| Pain | 4 |
| Headache Disorders, Secondary | 2 |
| Recurrence | 2 |
| Agnosia | 1 |
| Bronchiolitis Obliterans Syndrome | 1 |
Trials
Showing 1 to 25 of 101. Each trial links to its page on Pharma Observatory.
1 more trial matches. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.